| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure.
|
Circulation
|
2006
|
3.12
|
|
2
|
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.
|
Proc Natl Acad Sci U S A
|
2010
|
2.32
|
|
3
|
Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease.
|
Ann Neurol
|
2008
|
2.24
|
|
4
|
Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
|
Arch Neurol
|
2008
|
2.19
|
|
5
|
EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2.
|
Eur J Nucl Med Mol Imaging
|
2010
|
2.09
|
|
6
|
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.
|
Eur J Nucl Med Mol Imaging
|
2008
|
2.04
|
|
7
|
Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy.
|
Circulation
|
2008
|
1.82
|
|
8
|
Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas.
|
J Nucl Med
|
2010
|
1.61
|
|
9
|
Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.
|
J Neurosci
|
2005
|
1.58
|
|
10
|
The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.
|
Eur J Nucl Med Mol Imaging
|
2008
|
1.55
|
|
11
|
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.
|
Eur J Nucl Med Mol Imaging
|
2009
|
1.49
|
|
12
|
Effects of intravenous glucose on dopaminergic function in the human brain in vivo.
|
Synapse
|
2007
|
1.46
|
|
13
|
EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2.
|
Eur J Nucl Med Mol Imaging
|
2009
|
1.45
|
|
14
|
Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication.
|
Arch Neurol
|
2008
|
1.31
|
|
15
|
Striatal dopamine D1 and D2 receptors in burning mouth syndrome.
|
Pain
|
2003
|
1.29
|
|
16
|
Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.
|
Int J Neuropsychopharmacol
|
2007
|
1.27
|
|
17
|
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease.
|
Eur J Nucl Med Mol Imaging
|
2012
|
1.21
|
|
18
|
Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man.
|
Psychopharmacology (Berl)
|
2005
|
1.14
|
|
19
|
Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals.
|
Gastroenterology
|
2010
|
1.13
|
|
20
|
Altered dopamine D2 receptor binding in atypical facial pain.
|
Pain
|
2003
|
1.10
|
|
21
|
Increased brain fatty acid uptake in metabolic syndrome.
|
Diabetes
|
2010
|
1.10
|
|
22
|
C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity.
|
Synapse
|
2009
|
1.10
|
|
23
|
Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography.
|
Cancer
|
2002
|
1.07
|
|
24
|
Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease.
|
Mov Disord
|
2004
|
1.03
|
|
25
|
Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility.
|
J Cereb Blood Flow Metab
|
2008
|
1.02
|
|
26
|
Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
|
J Clin Psychopharmacol
|
2002
|
1.01
|
|
27
|
Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region.
|
J Cereb Blood Flow Metab
|
2006
|
1.00
|
|
28
|
C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2009
|
1.00
|
|
29
|
Posterior cortical atrophy: a rare form of dementia with in vivo evidence of amyloid-beta accumulation.
|
J Alzheimers Dis
|
2008
|
0.98
|
|
30
|
Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.
|
J Card Fail
|
2006
|
0.98
|
|
31
|
Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia.
|
Arch Gen Psychiatry
|
2005
|
0.97
|
|
32
|
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.
|
Neurobiol Aging
|
2012
|
0.96
|
|
33
|
Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects.
|
Neuroimage
|
2008
|
0.96
|
|
34
|
Age-related loss of extrastriatal dopamine D(2) -like receptors in women.
|
J Neurochem
|
2002
|
0.96
|
|
35
|
The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans.
|
Am J Physiol Endocrinol Metab
|
2008
|
0.95
|
|
36
|
Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain.
|
Eur J Neurosci
|
2004
|
0.94
|
|
37
|
Dopaminergic effects of caffeine in the human striatum and thalamus.
|
Neuroreport
|
2004
|
0.94
|
|
38
|
Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity.
|
Pain
|
2002
|
0.93
|
|
39
|
Sevoflurane and propofol increase 11C-flumazenil binding to gamma-aminobutyric acidA receptors in humans.
|
Anesth Analg
|
2004
|
0.92
|
|
40
|
Ketamine does not decrease striatal dopamine D2 receptor binding in man.
|
Psychopharmacology (Berl)
|
2002
|
0.92
|
|
41
|
Human biodistribution and radiation dosimetry of 11C-(R)-PK11195, the prototypic PET ligand to image inflammation.
|
Eur J Nucl Med Mol Imaging
|
2009
|
0.92
|
|
42
|
Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.
|
J Nucl Med
|
2004
|
0.91
|
|
43
|
Uptake of inflammatory cell marker [11C]PK11195 into mouse atherosclerotic plaques.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.90
|
|
44
|
Uptake of [N-methyl-11C]alpha-methylaminoisobutyric acid in untreated head and neck cancer studied by PET.
|
Eur J Nucl Med Mol Imaging
|
2002
|
0.90
|
|
45
|
Gender differences in brain serotonin transporter availability in panic disorder.
|
J Psychopharmacol
|
2010
|
0.89
|
|
46
|
Expectation of caffeine induces dopaminergic responses in humans.
|
Eur J Neurosci
|
2004
|
0.89
|
|
47
|
Brain serotonin 1A receptor binding in bulimia nervosa.
|
Biol Psychiatry
|
2004
|
0.89
|
|
48
|
Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.
|
Psychopharmacology (Berl)
|
2008
|
0.89
|
|
49
|
Measurement of central mu-opioid receptor binding in vivo with PET and [11C]carfentanil: a test-retest study in healthy subjects.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.88
|
|
50
|
Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans.
|
Cardiovasc Ther
|
2011
|
0.87
|
|
51
|
Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia.
|
Psychiatry Res
|
2005
|
0.87
|
|
52
|
Human obesity is characterized by defective fat storage and enhanced muscle fatty acid oxidation, and trimetazidine gradually counteracts these abnormalities.
|
Am J Physiol Endocrinol Metab
|
2011
|
0.87
|
|
53
|
Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data.
|
Eur J Nucl Med Mol Imaging
|
2009
|
0.87
|
|
54
|
Uptake of 11C-choline in mouse atherosclerotic plaques.
|
J Nucl Med
|
2010
|
0.87
|
|
55
|
Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.87
|
|
56
|
Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.
|
Synapse
|
2002
|
0.87
|
|
57
|
Dopamine D2/D3 receptor binding in the anterior cingulate cortex and executive functioning.
|
Psychiatry Res
|
2007
|
0.86
|
|
58
|
Reproducibility of striatal and thalamic dopamine D2 receptor binding using [11C]raclopride with high-resolution positron emission tomography.
|
J Cereb Blood Flow Metab
|
2010
|
0.86
|
|
59
|
COMT Val158Met genotype does not alter cortical or striatal dopamine D2 receptor availability in vivo.
|
Mol Imaging Biol
|
2009
|
0.85
|
|
60
|
Subanesthetic ketamine does not affect 11C-flumazenil binding in humans.
|
Anesth Analg
|
2005
|
0.85
|
|
61
|
Myocardial blood flow and adenosine A2A receptor density in endurance athletes and untrained men.
|
J Physiol
|
2008
|
0.85
|
|
62
|
Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects.
|
Pain
|
2004
|
0.84
|
|
63
|
[(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia.
|
Parkinsonism Relat Disord
|
2010
|
0.84
|
|
64
|
Exercise training in chronic heart failure: beneficial effects on cardiac (11)C-hydroxyephedrine PET, autonomic nervous control, and ventricular repolarization.
|
J Nucl Med
|
2002
|
0.84
|
|
65
|
Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia.
|
Neurosci Lett
|
2004
|
0.84
|
|
66
|
Development of an automated modular system for the synthesis of [11C]acetate.
|
Nucl Med Commun
|
2010
|
0.84
|
|
67
|
Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.
|
J Nucl Med
|
2010
|
0.84
|
|
68
|
Prolonged central mu-opioid receptor occupancy after single and repeated nalmefene dosing.
|
Neuropsychopharmacology
|
2005
|
0.84
|
|
69
|
[11C]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia.
|
Nucl Med Biol
|
2006
|
0.83
|
|
70
|
Brain dopamine d1 receptors in twins discordant for schizophrenia.
|
Am J Psychiatry
|
2006
|
0.83
|
|
71
|
Substantial thalamostriatal dopaminergic defect in Unverricht-Lundborg disease.
|
Epilepsia
|
2007
|
0.83
|
|
72
|
EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.82
|
|
73
|
Pancreatic glucose uptake in vivo in men with newly diagnosed type 1 diabetes.
|
J Clin Endocrinol Metab
|
2008
|
0.81
|
|
74
|
Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with [11C]raclopride PET.
|
J Psychopharmacol
|
2010
|
0.81
|
|
75
|
Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function.
|
Synapse
|
2008
|
0.81
|
|
76
|
Correlation of human cold pressor pain responses with 5-HT(1A) receptor binding in the brain.
|
Brain Res
|
2007
|
0.81
|
|
77
|
Human radiation dosimetry of [11C]MeAIB, a new tracer for imaging of system A amino acid transport.
|
Eur J Nucl Med Mol Imaging
|
2006
|
0.81
|
|
78
|
Amino acid uptake in the skeletal muscle measured using [11C]methylaminoisobutyrate (MEAIB) and PET.
|
Eur J Nucl Med Mol Imaging
|
2002
|
0.80
|
|
79
|
Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride.
|
Int J Neuropsychopharmacol
|
2004
|
0.80
|
|
80
|
Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
|
Neuroimage
|
2013
|
0.80
|
|
81
|
Human dosimetry of carbon-11 labeled N-butan-2-yl-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide extrapolated from whole-body distribution kinetics and radiometabolism in rats.
|
Mol Imaging Biol
|
2009
|
0.80
|
|
82
|
1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation.
|
J Nucl Med
|
2008
|
0.80
|
|
83
|
Biodistribution and blood metabolism of 1-11C-methyl-4-piperidinyl n-butyrate in humans: an imaging agent for in vivo assessment of butyrylcholinesterase activity with PET.
|
J Nucl Med
|
2004
|
0.79
|
|
84
|
Temperament trait Harm Avoidance associates with μ-opioid receptor availability in frontal cortex: a PET study using [(11)C]carfentanil.
|
Neuroimage
|
2012
|
0.79
|
|
85
|
PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter.
|
Nucl Med Biol
|
2002
|
0.78
|
|
86
|
Preliminary study of carbon-11 methionine PET in the evaluation of early response to therapy in advanced breast cancer.
|
Nucl Med Commun
|
2009
|
0.78
|
|
87
|
Positron emission tomography in at risk patients and in the progression of mild cognitive impairment to Alzheimer's disease.
|
J Alzheimers Dis
|
2010
|
0.78
|
|
88
|
Synthesis, radiolabeling and preliminary biological evaluation of radiolabeled 5-methyl-6-nitroquipazine, a potential radioligand for the serotonin transporter.
|
Bioorg Med Chem Lett
|
2002
|
0.77
|
|
89
|
Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects.
|
Neurosci Lett
|
2012
|
0.77
|
|
90
|
Xenon does not affect gamma-aminobutyric acid type A receptor binding in humans.
|
Anesth Analg
|
2008
|
0.77
|
|
91
|
The effects of lorazepam on extrastriatal dopamine D(2/3)-receptors-A double-blind randomized placebo-controlled PET study.
|
Psychiatry Res
|
2009
|
0.76
|
|
92
|
Cortical dopamine D2/D3 receptors and verbal memory in man.
|
Neuroimage
|
2010
|
0.76
|
|
93
|
Characterization of hepatic tumors using [11C]metomidate through positron emission tomography: comparison with [11C]acetate.
|
EJNMMI Res
|
2013
|
0.75
|
|
94
|
Differential associations between brain 5-HT(1A) receptor binding and response to pain versus touch.
|
J Neural Transm (Vienna)
|
2009
|
0.75
|
|
95
|
Brain Cholinergic Function and Response to Rivastigmine in Patients With Chronic Sequels of Traumatic Brain Injury: A PET Study.
|
J Head Trauma Rehabil
|
2017
|
0.75
|
|
96
|
Radiolabeling and biodistribution of methyl 2-(methoxycarbonyl)-2-(methylamino) bicyclo[2.1.1] -hexane -5-carboxylate, a potential neuroprotective drug.
|
Life Sci
|
2003
|
0.75
|
|
97
|
Cognitive decline and amyloid accumulation in patients with mild cognitive impairment.
|
Dement Geriatr Cogn Disord
|
2012
|
0.75
|